title: A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.
authors.affiliation: Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Gentile
authors.affiliation: Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
authors.forename: T D
authors.initials: TD
authors.lastname: Shanafelt
authors.affiliation: Dipartimento di diagnostica della patologia e delle cure ad alta complessità tecnologica, SS Molecular Diagnostics IRCCS S. Martino-IST, Genova, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Cutrona
authors.affiliation: Department of Oncology and Haematology, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Molica
authors.affiliation: Consiglio Nazionale delle Ricerche, Istituto di Fisiologia Clinica, Reggio Calabria, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Tripepi
authors.affiliation: Division of Haematology, Dipartimento Oncologico e Tecnologie Avanzate, Arcispedale S. Maria Nuova/IRCCS, Reggio Emilia, Italy.
authors.forename: I
authors.initials: I
authors.lastname: Alvarez
authors.affiliation: Divisione di Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia, Università La Sapienza, Roma, Italy.
authors.forename: F R
authors.initials: FR
authors.lastname: Mauro
authors.affiliation: Hematology Unit, Ospedale Vito Fazzi, Lecce, Italy.
authors.forename: N
authors.initials: N
authors.lastname: Di Renzo
authors.affiliation: Division of Haematology, Department of Biomedical Sciences, University of Catania and Ferrarotto Hospital, Catania, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Di Raimondo
authors.affiliation: Hematology Unit, Dipartimento di Onco-Ematologia, A.O. of Reggio Calabria, Reggio Calabria, Italy.
authors.forename: I
authors.initials: I
authors.lastname: Vincelli
authors.affiliation: Laboratory of Preclinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, Dipartimento Onco-Ematologico, Potenza, Italy.
authors.forename: K
authors.initials: K
authors.lastname: Todoerti
authors.affiliation: Direzione Scientifica IRCCS, San Martino IST, Genova, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Matis
authors.affiliation: Division of Haematology, Dipartimento di Medicina Interna,University of Messina, Messina, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Musolino
authors.affiliation: Department of Clinical Sciences and Community Health, University of Milano and Hematology CTMO, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Fabris
authors.affiliation: Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Vigna
authors.affiliation: Department of Oncology and Haematology, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Levato
authors.affiliation: Dipartimento di diagnostica della patologia e delle cure ad alta complessità tecnologica, SS Molecular Diagnostics IRCCS S. Martino-IST, Genova, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Zupo
authors.affiliation: Department of Hematology, Ospedale Santo Spirito, Pescara, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Angrilli
authors.affiliation: U.O.S. di Emato-Oncologia, Ospedale Garibaldi-Nesima, Catania, Italy.
authors.forename: U
authors.initials: U
authors.lastname: Consoli
authors.affiliation: Dipartimento ad Attività Integrata Oncologia, Centro di Riferimento Ematologico-Seconda Medicina, Azienda Ospedaliero-Universitaria, Ospedali Riuniti, Trieste, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Festini
authors.affiliation: Dipartimento di Oncologia, Unità di Ematologia, Ospedale San Vincenzo, Taormina, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Longo
authors.affiliation: Department of Clinical Sciences and Community Health, University of Milano and Hematology CTMO, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Cortelezzi
authors.affiliation: Dipartimento di Oncologia ed Ematologia, Hematology Unit, Department of Onco-Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Arcari
authors.affiliation: Department of Onco-hematology, Università di Modena Centro Oncologico Modenese, Policlinico Modena, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Federico
authors.affiliation: Divisione di Ematologia, Ospedale Papardo, Messina, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Mannina
authors.affiliation: Biotechnology Research Unit, Azienda Sanitaria Provinciale di Cosenza, Aprigliano, Cosenza, Italy.
authors.forename: A G
authors.initials: AG
authors.lastname: Recchia
authors.affiliation: Department of Clinical Sciences and Community Health, University of Milano and Hematology CTMO, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Neri
authors.affiliation: Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
authors.forename: N E
authors.initials: NE
authors.lastname: Kay
authors.affiliation: Direzione Scientifica IRCCS, San Martino IST, Genova, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Ferrarini
authors.affiliation: Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy.|Biotechnology Research Unit, Azienda Sanitaria Provinciale di Cosenza, Aprigliano, Cosenza, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Morabito
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D015331:Cohort Studies; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D064887:Observational Studies as Topic; D011379:Prognosis; D016016:Proportional Hazards Models; D012307:Risk Factors
chemical_list: D014408:Biomarkers, Tumor